On Invalid Date, Collplant Biotechnologies (NASDAQ: CLGN) reported Q1 2022 earnings per share (EPS) of -$0.36, up 130% year over year. Total Collplant Biotechnologies earnings for the quarter were -$3.86 million. In the same quarter last year, Collplant Biotechnologies's earnings per share (EPS) was $1.20.
As of Q3 2022, Collplant Biotechnologies's earnings has grown year over year. Collplant Biotechnologies's earnings in the past year totalled -$13.75 million.
What was CLGN's revenue last quarter?
On Invalid Date, Collplant Biotechnologies (NASDAQ: CLGN) reported Q1 2022 revenue of $66.00 thousand up 99.54% year over year. In the same quarter last year, Collplant Biotechnologies's revenue was $14.50 million.
What was CLGN's revenue growth in the past year?
As of Q3 2022, Collplant Biotechnologies's revenue has grown -93.97% year over year. This is 1,401.36 percentage points lower than the US Biotechnology industry revenue growth rate of 1,307.39%. Collplant Biotechnologies's revenue in the past year totalled $1.21 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.